2006Ophthalmic Plastic and Reconstructive SurgeryRequires access

Effect of 0.5% Apraclonidine on Ptosis in Horner Syndrome

Daniel C. Garibaldi, Holly B. Hindman, Michael P. Grant, Nicholas T. Iliff, Shannath L. Merbs

Open publisher page 33 citations

Abstract

In Brief To demonstrate the effect of apraclonidine on anisocoria and ptosis in Horner syndrome, one drop of 0.5% apraclonidine was instilled in both eyes of 3 patients who presented with acute Horner syndrome, and the effect on ptosis and anisocoria was documented. As reported in the literature, one drop of 0.5% apraclonidine reverses the anisocoria of Horner syndrome. In addition, 0.5% apraclonidine leads to a complete resolution of the ptosis associated with Horner syndrome, a finding reported once in the literature. Apraclonidine is a safe and readily available alternative to cocaine for the diagnosis of Horner syndrome. Apraclonidine (0.5%) readily reverses the anisocoria of Horner syndrome and leads to the resolution of ptosis, making it a safe and reliable alternative to cocaine for diagnostic testing in Horner syndrome.

About this research paper

What this paper is about

In Brief To demonstrate the effect of apraclonidine on anisocoria and ptosis in Horner syndrome, one drop of 0.5% apraclonidine was instilled in both eyes of 3 patients who presented with acute Horner syndrome, and the effect on ptosis and anisocoria was documented. As reported in the literature, one drop of 0.5% apraclonidine reverses the anisocoria of Horner syndrome. In addition, 0.5% apraclonidine leads to a complete resolution of the ptosis associated with Horner syndrome, a finding reported once in the literature. Apraclonidine is a safe and readily available alternative to cocaine for the diagnosis of Horner syndrome. Apraclonidine (0.5%) readily reverses the anisocoria of Horner syndrome and leads to the resolution of ptosis, making it a safe and reliable alternative to cocaine for diagnostic testing in Horner syndrome.

Why it matters

OpenAlex reports 33 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

In Brief To demonstrate the effect of apraclonidine on anisocoria and ptosis in Horner syndrome, one drop of 0.5% apraclonidine was instilled in both eyes of 3 patients who presented with acute Horner syndrome, and the effect on ptosis and anisocoria was documented. As reported in the literature, one drop of 0.5% apraclonidine reverses the anisocoria of Horner syndrome. In addition, 0.5% apraclonidine leads to a complete resolution of the ptosis associated with Horner syndrome, a finding reported once in the literature. Apraclonidine is a safe and readily available alternative to cocaine for the diagnosis of Horner syndrome. Apraclonidine (0.5%) readily reverses the anisocoria of Horner syndrome and leads to the resolution of ptosis, making it a safe and reliable alternative to cocaine for diagnostic testing in Horner syndrome.

Key concepts: Anisocoria, Ptosis, Horner syndrome, Medicine, Anesthesia, Surgery, Pupil, Psychology

Related papers

Back to paper searchBrowse research topicsOriginal source
Effect of 0.5% Apraclonidine on Ptosis in Horner Syndrome — Research Paper | ScholarLens